These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 23636235

  • 21. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study.
    Silverman RA, John-Stewart GC, Beck IA, Milne R, Kiptinness C, McGrath CJ, Richardson BA, Chohan B, Sakr SR, Frenkel LM, Chung MH.
    PLoS One; 2019; 14(10):e0223411. PubMed ID: 31584992
    [Abstract] [Full Text] [Related]

  • 22. Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania.
    Stete K, Glass TR, van Dam GJ, Ntamatungiro A, Letang E, de Dood CJ, Corstjens PLAM, Ndege R, Mapesi H, Kern WV, Hatz C, Weisser M, Utzinger J, Müller MC.
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006844. PubMed ID: 30332404
    [Abstract] [Full Text] [Related]

  • 23. Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.
    Komati S, Shaw PA, Stubbs N, Mathibedi MJ, Malan L, Sangweni P, Metcalf JA, Masur H, Hassim S.
    AIDS; 2010 Jul 31; 24(12):1849-55. PubMed ID: 20622529
    [Abstract] [Full Text] [Related]

  • 24. Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa.
    Fox MP, Sanne IM, Conradie F, Zeinecker J, Orrell C, Ive P, Rassool M, Dehlinger M, van der Horst C, McIntyre J, Wood R.
    AIDS; 2010 Aug 24; 24(13):2041-50. PubMed ID: 20613459
    [Abstract] [Full Text] [Related]

  • 25. Early immunologic response and subsequent survival among malnourished adults receiving antiretroviral therapy in Urban Zambia.
    Koethe JR, Limbada MI, Giganti MJ, Nyirenda CK, Mulenga L, Wester CW, Chi BH, Stringer JS.
    AIDS; 2010 Aug 24; 24(13):2117-21. PubMed ID: 20543657
    [Abstract] [Full Text] [Related]

  • 26. Active tuberculosis is associated with worse clinical outcomes in HIV-infected African patients on antiretroviral therapy.
    Siika AM, Yiannoutsos CT, Wools-Kaloustian KK, Musick BS, Mwangi AW, Diero LO, Kimaiyo SN, Tierney WM, Carter JE.
    PLoS One; 2013 Aug 24; 8(1):e53022. PubMed ID: 23301015
    [Abstract] [Full Text] [Related]

  • 27. Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): a prospective, international, randomised, placebo-controlled trial.
    Mfinanga SG, Kirenga BJ, Chanda DM, Mutayoba B, Mthiyane T, Yimer G, Ezechi O, Connolly C, Kapotwe V, Muwonge C, Massaga J, Sinkala E, Kohi W, Lyantumba L, Nyakoojo G, Luwaga H, Doulla B, Mzyece J, Kapata N, Vahedi M, Mwaba P, Egwaga S, Adatu F, Pym A, Joloba M, Rustomjee R, Zumla A, Onyebujoh P.
    Lancet Infect Dis; 2014 Jul 24; 14(7):563-71. PubMed ID: 24810491
    [Abstract] [Full Text] [Related]

  • 28. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania.
    Fawzi WW, Msamanga GI, Spiegelman D, Urassa EJ, McGrath N, Mwakagile D, Antelman G, Mbise R, Herrera G, Kapiga S, Willett W, Hunter DJ.
    Lancet; 1998 May 16; 351(9114):1477-82. PubMed ID: 9605804
    [Abstract] [Full Text] [Related]

  • 29. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS.
    Antivir Ther; 2003 Oct 16; 8(5):379-84. PubMed ID: 14640384
    [Abstract] [Full Text] [Related]

  • 30. Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia.
    Koethe JR, Blevins M, Nyirenda C, Kabagambe EK, Shepherd BE, Wester CW, Zulu I, Chiasera JM, Mulenga LB, Mwango A, Heimburger DC.
    J Int AIDS Soc; 2011 Apr 10; 14():19. PubMed ID: 21477359
    [Abstract] [Full Text] [Related]

  • 31. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
    Moh R, Danel C, Messou E, Ouassa T, Gabillard D, Anzian A, Abo Y, Salamon R, Bissagnene E, Seyler C, Eholié S, Anglaret X.
    AIDS; 2007 Nov 30; 21(18):2483-91. PubMed ID: 18025885
    [Abstract] [Full Text] [Related]

  • 32. Vitamin D status is associated with mortality, morbidity, and growth failure among a prospective cohort of HIV-infected and HIV-exposed Tanzanian infants.
    Sudfeld CR, Duggan C, Aboud S, Kupka R, Manji KP, Kisenge R, Fawzi WW.
    J Nutr; 2015 Jan 30; 145(1):121-7. PubMed ID: 25527666
    [Abstract] [Full Text] [Related]

  • 33. Six-month gain in weight, height, and CD4 predict subsequent antiretroviral treatment responses in HIV-infected South African children.
    Yotebieng M, Van Rie A, Moultrie H, Meyers T.
    AIDS; 2010 Jan 02; 24(1):139-46. PubMed ID: 19940744
    [Abstract] [Full Text] [Related]

  • 34. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.
    Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, Madec Y, Marcy O, Chan S, Prak N, Kim C, Lak KK, Hak C, Dim B, Sin CI, Sun S, Guillard B, Sar B, Vong S, Fernandez M, Fox L, Delfraissy JF, Goldfeld AE, CAMELIA (ANRS 1295–CIPRA KH001) Study Team.
    N Engl J Med; 2011 Oct 20; 365(16):1471-81. PubMed ID: 22010913
    [Abstract] [Full Text] [Related]

  • 35. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata.
    Palella FJ, Deloria-Knoll M, Chmiel JS, Moorman AC, Wood KC, Greenberg AE, Holmberg SD, HIV Outpatient Study Investigators.
    Ann Intern Med; 2003 Apr 15; 138(8):620-6. PubMed ID: 12693883
    [Abstract] [Full Text] [Related]

  • 36. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
    Maskew M, Fox MP, van Cutsem G, Chu K, Macphail P, Boulle A, Egger M, Africa FI.
    PLoS One; 2013 Apr 15; 8(6):e64392. PubMed ID: 23755122
    [Abstract] [Full Text] [Related]

  • 37. Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts.
    N'takpe JB, Gabillard D, Moh R, Gardiennet E, Emieme A, Badje A, Kouame GM, Toni TD, Karcher S, Carrou JL, Ménan H, Danel C, Eholie SP, Rouzioux C, Anglaret X.
    EBioMedicine; 2020 Jun 15; 56():102815. PubMed ID: 32512517
    [Abstract] [Full Text] [Related]

  • 38. Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study.
    Zhao Y, Wu Z, McGoogan JM, Shi CX, Li A, Dou Z, Ma Y, Qin Q, Brookmeyer R, Detels R, Montaner JSG.
    Clin Infect Dis; 2018 Feb 10; 66(5):727-734. PubMed ID: 29069362
    [Abstract] [Full Text] [Related]

  • 39. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M, Shafer LA, Chan S, Kasper K, Keynan Y.
    J Infect Public Health; 2018 Feb 10; 11(2):265-269. PubMed ID: 28826735
    [Abstract] [Full Text] [Related]

  • 40. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
    Hermans SM, Kiragga AN, Schaefer P, Kambugu A, Hoepelman AI, Manabe YC.
    PLoS One; 2010 May 07; 5(5):e10527. PubMed ID: 20479873
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.